NANO MRNA Co.,Ltd.
4571.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥109 | ¥136 | ¥202 | ¥264 |
| % Growth | -19.9% | -33% | -23.4% | – |
| Cost of Goods Sold | ¥30 | ¥25 | ¥43 | ¥41 |
| Gross Profit | ¥78 | ¥111 | ¥160 | ¥223 |
| % Margin | 72% | 81.9% | 78.9% | 84.4% |
| R&D Expenses | ¥422 | ¥647 | ¥1,120 | ¥1,924 |
| G&A Expenses | ¥0 | ¥0 | ¥0 | ¥0 |
| SG&A Expenses | ¥834 | ¥328 | ¥285 | ¥288 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | -¥422 | ¥0 | ¥1 | ¥72 |
| Operating Expenses | ¥834 | ¥975 | ¥1,406 | ¥2,284 |
| Operating Income | -¥755 | -¥864 | -¥1,246 | -¥2,061 |
| % Margin | -696.1% | -637.9% | -616.3% | -780.6% |
| Other Income/Exp. Net | -¥77 | ¥87 | -¥62 | ¥182 |
| Pre-Tax Income | -¥833 | -¥778 | -¥1,308 | -¥1,879 |
| Tax Expense | ¥3 | ¥2 | ¥2 | ¥3 |
| Net Income | -¥835 | -¥780 | -¥1,311 | -¥1,882 |
| % Margin | -769.8% | -575.6% | -648.4% | -712.7% |
| EPS | -11.85 | -11.1 | -18.7 | -26.9 |
| % Growth | -6.8% | 40.6% | 30.5% | – |
| EPS Diluted | -11.85 | -11.1 | -18.7 | -26.9 |
| Weighted Avg Shares Out | 71 | 70 | 70 | 70 |
| Weighted Avg Shares Out Dil | 71 | 70 | 70 | 70 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥31 | ¥26 | ¥25 | ¥13 |
| Interest Expense | ¥0 | ¥10 | ¥6 | ¥2 |
| Depreciation & Amortization | ¥0 | ¥1 | ¥0 | ¥4 |
| EBITDA | -¥833 | -¥863 | -¥1,246 | -¥2,058 |
| % Margin | -767.2% | -636.9% | -616.2% | -779.4% |